{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "04/08/2026",
      "update_type": "New",
      "initial_posting_date": "04/08/2026",
      "package_ndc": "0006-3066-03",
      "generic_name": "Aprepitant Oral Powder for Suspension",
      "contact_info": "800-672-6372",
      "related_info": "To be discontinued in approximately early-September 2026.",
      "openfda": {
        "application_number": [
          "NDA207865"
        ],
        "brand_name": [
          "EMEND"
        ],
        "generic_name": [
          "APREPITANT"
        ],
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "product_ndc": [
          "0006-3066",
          "0006-0461",
          "0006-0462",
          "0006-3862",
          "0006-0464"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "APREPITANT"
        ],
        "rxcui": [
          "403810",
          "403811",
          "404465",
          "404466",
          "644088",
          "644278",
          "754508",
          "754509",
          "1729308",
          "1729311"
        ],
        "spl_id": [
          "428f7828-6d1c-438b-a17d-b4af0700c740"
        ],
        "spl_set_id": [
          "696f9e80-9cae-403b-de9e-078343ce4713"
        ],
        "package_ndc": [
          "0006-0461-02",
          "0006-0461-01",
          "0006-0461-06",
          "0006-0461-12",
          "0006-0462-01",
          "0006-0462-06",
          "0006-3862-03",
          "0006-3862-13",
          "0006-0464-01",
          "0006-0464-10",
          "0006-0464-05",
          "0006-3066-01",
          "0006-3066-03"
        ],
        "nui": [
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185507",
          "N0000185506"
        ],
        "pharm_class_moa": [
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "1NF15YR6UY"
        ]
      },
      "update_date": "04/08/2026",
      "therapeutic_category": [
        "Gastroenterology"
      ],
      "presentation": "Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)",
      "company_name": "Merck Sharp & Dohme LLC",
      "status": "To Be Discontinued"
    }
  ]
}